AD
Adaptive Biotechnologies
ADPT·NASDAQSeattle WAFounded 2009800 employees
Small CapbiotechPublicOncologyImmunology
Platform: clonoSEQ Immuno
Market Cap
$1.5B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (ADPT)
Loading ADPT stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Talamavacamten | ADP-8484 | Phase 1/2 | 1 | IL-17A | MyelofibrosisSchizophrenia | ||
| ADP-7169 | ADP-7169 | Approved | 3 | LAG-3 | Atopic Derm |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)